GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%
R&D Innovation to Lead the Future, Deepening Customer Value Creation Sustained High Revenue Growth: GenScript Groups five-year CAGR stands at an impressive...
Sherry Shao Davidr Liu Genscript Probio Professor At Harvard University Genscript Group University Of Pennsylvania
Source: prnewswire.com